Arteris Announces Financial Results for the Fourth Quarter and

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2021 and Estimated First Quarter and Full Year 2022 Guidance

| More EDA News

Arteris, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
(unaudited)

	As of
	December 31, 2021			December 31, 2020
ASSETS
Currents assets:
Cash	$	85,825		$	11,744
Accounts receivable, net		13,873			14,350
Prepaid expenses and other current assets		6,949			2,858
Total current assets		106,647			28,952
Property and equipment, net		2,438			2,365
Operating lease right-of-used assets		2,765			2,753
Intangibles, net		2,959			3,409
Goodwill		2,677			2,677
Other assets		2,957			2,580
TOTAL ASSETS	$	120,443		$	42,736
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT
Current liabilities:
Account payable	$	1,722		$	1,116
Accrued expenses and other current liabilities		10,573			7,249
Operating lease liabilities, current		961			767
Deferred revenue, current		28,403			17,894
Vendor financing arrangements, current		833			643
Term loan		—			557
Total current liabilities		42,492			28,226
Deferred revenue, noncurrent		20,773			15,014
Operating lease liabilities, noncurrent		1,851			2,079
Vendor financing arrangements, noncurrent		266			727
Other liabilities		2,157			2,986
Total liabilities		67,539			49,032
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, par value of $0.001, no shares authorized, issued, and outstanding at December 31, 2021; 4,471,316 shares authorized, issued and outstanding at December 31, 2020 (aggregate liquidation preference of zero and $5,768 at December 31, 2021 and 2020, respectively)		—			5,712
Stockholders' equity (deficit):
Preferred stock, par value of $0.001—10,000,000 and no shares authorized at December 31, 2021 and 2020, respectively; no shares issued and outstanding at December 31, 2021 and 2020		—			—
Common stock, par value of $0.001—300,000,000 and 31,525,154 shares authorized at December 31, 2021 and 2020, respectively; 31,530,682 and 18,486,989 shares issued and outstanding at December 31, 2021 and 2020, respectively		31			18
Additional paid-in-capital		91,945			3,612
Accumulated other comprehensive loss		(81	)		(31	)
Accumulated deficit		(38,991	)		(15,607	)
Total stockholders' equity (deficit)		52,904			(12,008	)
TOTAL LIABILITIES REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)	$	120,443		$	42,736

« Previous Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 Next Page »